Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Szema AM et al. - Biotechnology in the form of novel but currently available and in-practice medical devices, as well as new therapeutic agents, have expanded the armamentarium for safely managing patients with HAE pre- and intraoperatively.

Related Articles

Human C1-Esterase Inhibitor Concentrate (Berinert(R))
BioDrugs, 11/10/09    Relevance Score: 87%

Anaphylaxis and angioedema
Dermatology in Practice, 10/09/09    Relevance Score: 87%

Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency
Journal of Allergy and Clinical Immunology, 10/07/09    Relevance Score: 87%

Supraglottic swelling may not correlate with tongue swelling in angiotensin converting enzyme inhibitor-induced angioedema
The Laryngoscope, 11/06/09    Relevance Score: 84%

Pathogenesis and laboratory diagnosis of hereditary angioedema
Allergy and Asthma Proceedings, 10/09/09    Relevance Score: 84%

Today in Allergy/Immunology...keeping you current

Traffic-Related Air Pollution and the Development of Asthma and Allergies During The First 8 Years of Life
American Journal of Respiratory and Critical Care Medicine, 12/07/09

Severe atopic dermatitis treated with everolimus
Journal of Dermatological Treatment , 12/07/09

Interferon-gamma (INF-gamma) release test can detect cutaneous adverse effects to statins
International Journal of Dermatology, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address